Stocklytics Platform
Asset logo for symbol MD
MEDNAX
MD58
$12.82arrow_drop_down2.58%-$0.33
Asset logo for symbol MD
MD58

$12.82

arrow_drop_down2.58%
Key Stats
Open$13.10
Prev. Close$13.14
EPS-1.19
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range12.50
15.13
52 Week Range6.62
17.60
Ratios
Revenue-
EPS-1.19
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Analyst rating

An aggregate view of professional's ratings.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Stock Performance

MD-
US Healthcare Sector-
US Market-
warning

MD / Market

MD lose to the US Market which returned 0.69% over the last twenty four hours.
warning

MD / Healthcare Sector

MD lose to the US Healthcare sector which returned 2.48% over the last twenty four hours.

MEDNAX (MD) Statistics

MEDNAX Inc (MD) is a leading provider of physician services, including neonatal, anesthesia, maternal-fetal, and pediatric subspecialty care. The company operates through its network of affiliated healthcare providers, serving medical facilities across the United States. With a strong focus on delivering high-quality patient care, MEDNAX has established itself as a trusted name in the healthcare industry.
When it comes to valuation metrics, MEDNAX Inc (MD) stands out as a solid investment choice. The company has a favorable price-to-earnings ratio, indicating that its stock is reasonably priced compared to its earnings. Additionally, MEDNAX has a strong enterprise value-to-EBITDA ratio, which suggests that it is generating healthy cash flows and is capable of paying off its debts. These valuation metrics make MEDNAX an attractive investment opportunity for investors.
add MEDNAX to watchlist

Keep an eye on MEDNAX

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has MEDNAX (MD) stock's performance compared to its sector and the market over the past year?

Over the past year, MEDNAX (MD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.93%, MEDNAX has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 35.52%, it has fallen short of the market average. This comparison highlights MEDNAX 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of MEDNAX (MD) stock?

The PE ratio for MEDNAX (MD) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of MEDNAX (MD) stock?

The Earnings Per Share (EPS) for MEDNAX (MD), calculated on a diluted basis, is -$1.19. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of MEDNAX (MD) stock?

The operating margin for MEDNAX (MD) is 11.57%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of MEDNAX (MD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of MEDNAX (MD) is $218.25M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does MEDNAX (MD) have?

MEDNAX (MD) has a total debt of $662.31M. The net debt, which accounts for cash and cash equivalents against the total debt, is $432.37M.

Take Your Investments to a Whole New Level